GMAB and GEN:DC Related Headlines
Go Back- Genmab A/S (GEN:DC) (GMAB) PT Lowered to DKK2,600 at UBS
- Jefferies Reiterates Buy Rating on Genmab A/S (GEN:DC) (GMAB)
- Jefferies Resumes Genmab A/S (GEN:DC) (GMAB) at Buy
- Genmab A/S (GEN:DC) (GMAB) PT Raised to DKK2,750 at UBS
- Genmab A/S (GEN:DC) (GMAB) PT Raised to DKK2,500 at Barclays
- Genmab A/S (GEN:DC) (GMAB) PT Raised to DKK2,400 at Deutsche Bank
- Genmab A/S (GEN:DC) (GMAB) PT Raised to DKK2,000 at Deutsche Bank
- Genmab A/S (GEN:DC) (GMAB) PT Raised to DKK2,700 at UBS
- Genmab A/S (GEN:DC) (GMAB) PT Raised to DKK1,650 at JPMorgan
- Genmab A/S (GEN:DC) (GMAB) PT Raised to DKK1,900 at Deutsche Bank
- Genmab A/S (GEN:DC) (GMAB) PT Raised to DKK2,600 at UBS
- Genmab A/S (GEN:DC) (GMAB) PT Lowered to DKK2,500 at UBS
- Barclays Reiterates Overweight Rating on Genmab A/S (GEN:DC) (GMAB)

